FitRx Review

FitRx: the rare platform that tries insurance first

Most GLP-1 telehealth startups quietly skip insurance entirely and sell you cash-pay compounded medication. FitRx is built around the opposite bet. Its headline pitch is that it will coordinate with your insurer to get you a real brand-name GLP-1 — Ozempic, Wegovy, Zepbound, or Mounjaro — and if your plan plays along, your share can land as low as roughly twenty-five dollars a month. For an insured patient who actually wants the FDA-approved pen and not a compounded copy, that is a genuinely different proposition, and it's the main reason to look here.

The catch is in the word 'coordination.' FitRx isn't your insurer, and it can't force a plan to cover a weight-loss drug it has decided to exclude. So the low number is a best case, not a promise. If your coverage cooperates, FitRx is one of the cheapest legitimate routes to brand-name medication in this whole category. If it doesn't, you fall back to the cash compounded plan — and that's where most people will actually land.

How the two-track pricing really works

There are two distinct paths, and they are priced nothing alike. The brand track runs through your insurance and is the one that can reach the low double digits per month — but only because your plan is paying the rest of a list price that runs well over a thousand dollars. The cash track is the fallback: compounded semaglutide starting at $151 a month, and that rate is quoted on a quarterly purchase, meaning you commit to and pay for a three-month supply up front rather than month to month.

For context, $151 sits a little under the category median of about $170, so the cash compounded plan is competitively priced but not a category-low loss leader. FitRx is currently running a limited-time discount on its weight-loss program as well, though promotional pricing comes and goes — treat any teaser rate as a reason to confirm the real ongoing number before you commit to a quarter.

• Brand track: Ozempic, Wegovy, Zepbound, Mounjaro through insurance coordination — potentially a very low monthly copay, entirely dependent on your plan.
• Cash track: compounded semaglutide from $151/month, billed quarterly, no insurance required.
• What the cash price includes: the medication itself, free shipping from U.S.-based pharmacies, and 24/7 access to licensed providers at no extra cost.

Medications and how they reach you

On the brand side FitRx covers all four of the major GLP-1 and dual-agonist pens, which means both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are on the menu if your insurance approves them. On the cash side, though, the only compounded option is semaglutide. There is no compounded tirzepatide here. If you've decided tirzepatide is the molecule you want and you don't have insurance coverage for it, FitRx simply can't serve you — that's a hard limit worth knowing before you sign up.

Everything ships from U.S.-based pharmacies with free delivery, the consultation is free, and FitRx says supplies come included with the medication. Care is delivered by licensed providers available in all fifty states plus Washington, D.C., so geography isn't a barrier the way it is with some smaller operators.

What actually sets FitRx apart

Two things. First is the insurance-first model — most competitors won't even attempt it, so FitRx is one of the few places an insured patient can plausibly get a brand-name pen for a small copay rather than a four-figure cash price. Second is breadth: FitRx isn't a weight-loss specialist. It's a general telehealth platform that also handles birth control, mental health, hair loss, ED, skincare, and primary care.

That breadth cuts both ways. If you'd rather keep your prescriptions under one roof, it's a convenience. But it also means weight management is one of many lines of business rather than the entire focus, and you won't get the deep, single-minded program design you'd find at a dedicated GLP-1 clinic. There's no dedicated lab panel mentioned, and the coaching is structured as an optional add-on you choose into — it isn't baked into the base cash price the way some rivals bundle it.

Who it's for, and who should look elsewhere

• Choose FitRx if: you have insurance and want a real shot at a brand-name GLP-1 for a low copay, or you want compounded semaglutide as a clean fallback, or you like consolidating multiple health needs on one platform.
• Skip it if: you want compounded tirzepatide (not offered), you want a weight-loss-only program with built-in coaching and labs, or you have no insurance and the insurance-coordination angle — FitRx's whole selling point — doesn't apply to you.

Trust and medical oversight

FitRx is LegitScript certified, a third-party verification that the pharmacy and telehealth operation meet legal and safety standards — a badge that screens out the sketchier end of this market, and one we confirmed directly. There are no FDA warning letters or enforcement actions on file against FitRx in our records, and the platform consistently states that prescriptions come from licensed U.S. providers and that fulfillment runs through U.S.-based pharmacies. That's a reassuring baseline. As always with compounded medication, remember it isn't FDA-approved the way the brand pens are; that's a trade-off inherent to every cash compounded plan, not a FitRx-specific flaw. You can see how we weigh these factors in our scoring methodology.

Bottom line

FitRx is most compelling for insured patients — it's one of the few telehealth services that genuinely tries to get you a brand-name GLP-1 through your plan, and when that works the price is hard to beat. For everyone else, it's a solid, LegitScript-certified, nationwide compounded-semaglutide option at $151 a month, with the convenience of a broad platform behind it. Just go in clear-eyed: the eye-catching low number depends entirely on your insurance, the cash plan asks you to pay a quarter at a time, and tirzepatide isn't available unless your coverage pays for the brand.

For a side-by-side, Maximus ($149.99/month) and bmiMD ($99/month) are the most comparable options to weigh against FitRx.